PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, and Intus Bio, a leader in microbiome research and discovery, today unveiled GutID, the first commercial human ...
Hosted on MSN58m
Health Care AI, Intended To Save Money, Turns Out To Require a Lot of Expensive HumansDespite the hype over artificial intelligence in medicine, the systems require consistent monitoring and staffing to put in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback